Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mitemcinal (GM-611) in diabetic gastroparesis
NCT00050882Phase 2Completed
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mitemcinal in diabetic gastroparesis, sponsored by Chugai Pharmaceutical Co., Ltd.. Status: completed.
02
Drugs
mitemcinal
03
Conditions
diabetic gastroparesis
Beyond the preview
Go deeper on NCT00050882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00050882.